Restless legs syndrome in non-dialysis renal patients: is it really that common?
- PMID: 25348239
- PMCID: PMC4265660
- DOI: 10.5664/jcsm.4366
Restless legs syndrome in non-dialysis renal patients: is it really that common?
Abstract
Background: Sleep disorders are frequent in chronic kidney disease (CKD). Among them, restless legs syndrome (RLS) may affect up to 60% of patients on dialysis, and it has been related to a poor quality of life and higher cardiovascular risk. Despite its high prevalence in advanced stages of renal disease, RLS frequency in non-dialysis CKD has not been clearly established. The aim of this study was to assess the frequency of RLS in non-dialysis CKD patients (stages 2 to 4) followed in a reference nephrology outpatient clinic.
Methods: A standardized questionnaire following the international RLS study group diagnostic criteria was self-administered by 110 patients regularly followed in the nephrology clinic. The series comprised 69 men and 41 women, aged 68 ± 13.2 years, with mean serum creatinine of 1.7 ± 0.8 mg/dL. Subsequently, patients classified as probable RLS according to the questionnaire underwent a systematic neurological examination. The presence of peripheral artery disease was evaluated by the ankle-brachial index (ABI).
Results: The frequency of probable RLS according to the questionnaire results was 21% (17% for men and 27% for women). However, after thorough neurological examination, the diagnosis of RLS was confirmed in only 5 patients. Therefore, the overall definitive RLS frequency was 4.5% (within the prevalence reported for the general population) and was higher among women (9.7% vs 0.2%). In the remaining cases symptoms were due to leg discomfort related with other disorders. Patients with probable and improbable RLS were not significantly different in age, ABI, diabetes, and other comorbid circumstances, except for tricyclic antidepressant prescription, which was more frequent in the probable RLS group (17% vs 2%). Renal function was better in definitive RLS patients than cases classified as probable RLS by the questionnaire but not confirmed after neurological exam.
Conclusions: Although RLS can represent an early manifestation of CKD, its prevalence seems very close to that reported for the general population. Diagnostic confirmation of RLS dramatically falls after expert examination, raising the question whether, in the study of RLS cohorts, CKD has a potentially causal relationship or is a confounding factor associated with other causes of leg discomfort.
Keywords: IRLSSG questionnaire; RLS mimics; chronic renal failure; prevalence; restless legs syndrome.
© 2015 American Academy of Sleep Medicine.
Similar articles
-
Restless legs syndrome in end-stage renal disease.Sleep Med. 2004 May;5(3):309-15. doi: 10.1016/j.sleep.2004.01.014. Sleep Med. 2004. PMID: 15165541 Review.
-
Prevalence and clinical characteristics of restless legs syndrome in chronic kidney disease patients.Sleep Med. 2011 Dec;12(10):1031-3. doi: 10.1016/j.sleep.2011.06.014. Epub 2011 Oct 28. Sleep Med. 2011. PMID: 22036105
-
Restless Legs Syndrome: An Unresolved Uremic Disorder after Renal Transplantation.Nephron. 2018;139(1):23-29. doi: 10.1159/000486401. Epub 2018 Feb 1. Nephron. 2018. PMID: 29393274
-
Restless legs syndrome in patients on dialysis.Saudi J Kidney Dis Transpl. 2009 May;20(3):378-85. Saudi J Kidney Dis Transpl. 2009. PMID: 19414938
-
Restless Legs Syndrome in Patients With Chronic Kidney Disease.Semin Nephrol. 2015 Jul;35(4):347-58. doi: 10.1016/j.semnephrol.2015.06.006. Semin Nephrol. 2015. PMID: 26355253 Review.
Cited by
-
Restless Leg Syndrome in Peripheral Artery Disease: Prevalence among Patients with Claudication and Benefits from Low-Intensity Exercise.J Clin Med. 2019 Sep 6;8(9):1403. doi: 10.3390/jcm8091403. J Clin Med. 2019. PMID: 31500156 Free PMC article.
-
Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder.Nat Sci Sleep. 2023 Oct 21;15:851-859. doi: 10.2147/NSS.S427403. eCollection 2023. Nat Sci Sleep. 2023. PMID: 37886689 Free PMC article.
-
Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS).BMC Nephrol. 2017 Aug 1;18(1):258. doi: 10.1186/s12882-017-0660-0. BMC Nephrol. 2017. PMID: 28764654 Free PMC article.
References
-
- Pierratos A, Hanly PJ. Sleep disorders over the full range of chronic kidney disease. Blood Purif. 2011;31:146–50. - PubMed
-
- Mucsi I, Molnar MZ, Ambrus C, et al. Restless legs syndrome, Insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant. 2005;20:571–7. - PubMed
-
- La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant. 2011;26:1976–83. - PubMed
-
- Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Pantzaris MC, Stefanidis I, Sakkas GK. Epidemiology, impact, and treatment options of restless legs syndrome in endstage renal disease patients: an evidence-based review. Kidney Int. 2014;85:1275–82. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical